Literature DB >> 2347309

The X protein of the hepatitis B virus acts as a transcription factor when targeted to its responsive element.

T Unger1, Y Shaul.   

Abstract

The X protein of hepatitis B virus (HBV) stimulates transcription of a large number of viral enhancers. This protein augments the activity of the HBV enhancer through a specific cis element, termed X responsive element (XRE). Multimers of XRE exhibit enhancer activity which is further stimulated by X. XRE binds multiple cellular transcription factors one of which is the C/EBP. We have constructed the DB gene containing the DNA-binding domain of the C/EBP. This gene efficiently represses the enhancer activity of the XRE by competitive displacement of the XRE-binding factors. Under these conditions, X was found to have only a partially stimulatory effect on transcription, suggesting that the XRE-binding proteins are required for the activity of X. In contrast, an X-DB hybrid protein that binds to the XRE is a strong transcription factor and acts without additional XRE-binding proteins. Furthermore, studies of X mutants revealed that the carboxy-terminus of the protein is required for this activation. These data show that X directly stimulates the cellular transcription machinery, possibly by protein-protein interaction with the XRE-binding factors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2347309      PMCID: PMC551895          DOI: 10.1002/j.1460-2075.1990.tb08315.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  38 in total

Review 1.  Regulation of HIV and HTLV gene expression.

Authors:  H Varmus
Journal:  Genes Dev       Date:  1988-09       Impact factor: 11.361

2.  Identification of a cellular transcription factor involved in E1A trans-activation.

Authors:  I Kovesdi; R Reichel; J R Nevins
Journal:  Cell       Date:  1986-04-25       Impact factor: 41.582

3.  Interaction of a gene-specific transcription factor with the adenovirus major late promoter upstream of the TATA box region.

Authors:  M Sawadogo; R G Roeder
Journal:  Cell       Date:  1985-11       Impact factor: 41.582

4.  Nucleotide sequence of an infectious molecularly cloned genome of ground squirrel hepatitis virus.

Authors:  C Seeger; D Ganem; H E Varmus
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

5.  Nucleotide sequence of a cloned woodchuck hepatitis virus genome: evolutional relationship between hepadnaviruses.

Authors:  K Kodama; N Ogasawara; H Yoshikawa; S Murakami
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

6.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

7.  Identification of a promoter element located upstream from the hepatitis B virus X gene.

Authors:  M Treinin; O Laub
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

8.  Regulation of alpha genes of herpes simplex virus: expression of chimeric genes produced by fusion of thymidine kinase with alpha gene promoters.

Authors:  L E Post; S Mackem; B Roizman
Journal:  Cell       Date:  1981-05       Impact factor: 41.582

9.  cis and trans activation of globin gene transcription in transient assays.

Authors:  R Treisman; M R Green; T Maniatis
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

10.  A human hepatitis B viral enhancer element.

Authors:  Y Shaul; W J Rutter; O Laub
Journal:  EMBO J       Date:  1985-02       Impact factor: 11.598

View more
  37 in total

1.  Alternate translation initiation on hepatitis B virus X mRNA produces multiple polypeptides that differentially transactivate class II and III promoters.

Authors:  L Kwee; R Lucito; B Aufiero; R J Schneider
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

2.  Diversity of hepatitis B virus X gene-related transcripts in hepatocellular carcinoma: a novel polyadenylation site on viral DNA.

Authors:  C Hilger; I Velhagen; H Zentgraf; C H Schröder
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  pX, the HBV-encoded coactivator, suppresses the phenotypes of TBP and TAFII250 mutants.

Authors:  I Haviv; Y Matza; Y Shaul
Journal:  Genes Dev       Date:  1998-04-15       Impact factor: 11.361

4.  XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation.

Authors:  N Kuzhandaivelu; Y S Cong; C Inouye; W M Yang; E Seto
Journal:  Nucleic Acids Res       Date:  1996-12-01       Impact factor: 16.971

5.  Hepatitis B virus pX targets TFIIB in transcription coactivation.

Authors:  I Haviv; M Shamay; G Doitsh; Y Shaul
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

6.  Expression of the X protein of hepatitis B virus in insect cells using recombinant baculoviruses.

Authors:  R Klein; C H Schröder; H Zentgraf
Journal:  Virus Genes       Date:  1991-04       Impact factor: 2.332

7.  Evaluation of transcriptional efficiency of hepatitis B virus covalently closed circular DNA by reverse transcription-PCR combined with the restriction enzyme digestion method.

Authors:  Yu-Chi Chou; King-Song Jeng; Mong-Liang Chen; Hsiao-Hui Liu; Tzu-Ling Liu; Ya-Ling Chen; Yu-Chih Liu; Cheng-po Hu; Chungming Chang
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

8.  Hepatitis B virus X protein induces RNA polymerase III-dependent gene transcription and increases cellular TATA-binding protein by activating the Ras signaling pathway.

Authors:  H D Wang; A Trivedi; D L Johnson
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

9.  The hepatitis B virus X protein increases the cellular level of TATA-binding protein, which mediates transactivation of RNA polymerase III genes.

Authors:  H D Wang; C H Yuh; C V Dang; D L Johnson
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

10.  Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis.

Authors:  Y D Yoo; H Ueda; K Park; K C Flanders; Y I Lee; G Jay; S J Kim
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.